DISRUPTION OF THE FUNCTION OF TUMOR-SUPPRESSOR GENE P53 BY THE HEPATITIS-B VIRUS X-PROTEIN AND HEPATOCARCINOGENESIS

被引:31
作者
TAKADA, S
TSUCHIDA, N
KOBAYASHI, M
KOIKE, K
机构
[1] JAPANESE FDN CANC RES,INST CANC,DEPT GENE RES,TOSHIMA KU,TOKYO 170,JAPAN
[2] TOKYO MED & DENT UNIV,DEPT MOLEC & CELLULAR ONCOL,BUNKYO KU,TOKYO 113,JAPAN
关键词
HEPATITIS B VIRUS; X PROTEIN; TRANSACTIVATION; TUMOR-SUPPRESSOR GENE P53; HEPATOCARCINOGENESIS;
D O I
10.1007/BF01197776
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The X gene of the hepatitis B virus codes for a small basic protein and is able to transactivate viral and cellular genes, although the X protein exhibits no DNA-binding activity. The mechanism of transactivation by X protein has been suggested to be via protein-protein interaction(s). We first demonstrated that X protein had amino acid sequences homologous to the functionally essential domain of Kunitz-type serine protease inhibitors and that those sequences were indispensable for the transactivation function. We demonstrated that X protein exhibited an inhibitor activity against hepatic serine proteases, and subsequently found that the protein activated X gene transcription in HepG2 cells and that the X responsive element was localized in the minimal promoter of the X gene. In contrast, the tumor-suppressor gene p53, but not mutant p53, remarkably reduced transcription from the minimal promoter. This p53 repression on the X gene promoter was cancelled by X gene co-expression, probably indicating that the X protein disrupts the p53 tumor suppressor function in the nucleus. All data suggest that X protein leads to transactivation of cellular oncogenes by preventing an interaction between p53 and cellular transcription factor(s) consisting of the basal transcriptional machinery.
引用
收藏
页码:593 / 601
页数:9
相关论文
共 48 条
[1]  
ARII M, 1992, ONCOGENE, V7, P397
[2]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[3]  
BEASLEY RP, 1981, LANCET, V2, P1129
[4]  
BRECHOT C, 1981, LANCET, V2, P765
[5]   STATE OF HEPATITIS-B VIRUS-DNA IN HEPATOCYTES OF PATIENTS WITH HEPATITIS-B SURFACE ANTIGEN-POSITIVE AND ANTIGEN-NEGATIVE LIVER-DISEASES [J].
BRECHOT, C ;
HADCHOUEL, M ;
SCOTTO, J ;
FONCK, M ;
POTET, F ;
VYAS, GN ;
TIOLLAIS, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (06) :3906-3910
[6]   TRANSCRIPTIONAL ACTIVATION OF HOMOLOGOUS AND HETEROLOGOUS GENES BY THE HEPATITIS-B VIRUS X-GENE PRODUCT IN CELLS PERMISSIVE FOR VIRAL REPLICATION [J].
COLGROVE, R ;
SIMON, G ;
GANEM, D .
JOURNAL OF VIROLOGY, 1989, 63 (09) :4019-4026
[7]  
DEJIAN A, 1984, P NATL ACAD SCI USA, V81, P5350
[8]  
DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P475
[9]  
FEITELSON MA, 1993, ONCOGENE, V8, P1109
[10]  
FINLAY CA, 1988, CELL, V57, P1083